Marta Krejčí
- Hematology top 1%
- Multiple Myeloma Research and Treatments 54
- Hematopoietic Stem Cell Transplantation 17
- Oncology top 5%
- Cancer Treatment and Pharmacology 17
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 14
- Myeloproliferative Neoplasms: Diagnosis and Treatment 11
- Orthopedics and Sports Medicine top 10%
- Transplantation top 10%
-
- Histiocytic Disorders and Treatments 29
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 18
-
- Lymphoma Diagnosis and Treatment 10
- Co-authors
- Roman HájekZdeněk AdamJiřı́ MayerLuděk PourJiří VorlíčekTomáš BüchlerPaul ChengBrian G.M. Durie
- Cited by
- HematologyOncologyGenetics
- Partner nations
- CzechiaGreeceUnited States
In The Last Decade
Marta Krejčí
124 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Hematology 832
- Oncology 574
- Genetics 190
- Orthopedics and Sports Medicine 86
- Transplantation 26
Countries citing papers authored by Marta Krejčí
This map shows the geographic impact of Marta Krejčí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Krejčí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Krejčí more than expected).
Fields of papers citing papers by Marta Krejčí
This network shows the impact of papers produced by Marta Krejčí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Krejčí. The network helps show where Marta Krejčí may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marta Krejčí, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 4 | |
| 6 | 2019 | 0 | |
| 7 | 2019 | 2 | |
| 8 | 2017 | 0 | |
| 9 | [The patient complains of spinal pain or fatigue and weakness. How do I recognize whether their cause is spondylarthrosis, the patients age or multiple myeloma?]. | 2016 | 1 |
| 10 | Diagnostika a léčba Waldenströmovy makroglobulinemie | 2014 | 0 |
| 11 | 2012 | 22 | |
| 12 | 2012 | 10 | |
| 13 | 2012 | 2 | |
| 14 | Choroby způsobené ukládáním monoklonálních imunoglobulinů | 2011 | 0 |
| 15 | 2010 | 15 | |
| 16 | 2009 | 24 | |
| 17 | Histiocytóza z Langerhansových buněk u dospělých osob | 2008 | 0 |
| 18 | Exathema and herpes zoster infection during Velcade use incidence, treatment and profylaxis | 2006 | 1 |
| 19 | 2006 | 11 | |
| 20 | 2005 | 9 |
About Marta Krejčí
Marta Krejčí is a scholar working on Hematology, Genetics and Oncology, having authored 155 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (54 papers), Histiocytic Disorders and Treatments (29 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers), Hematopoietic Stem Cell Transplantation (17 papers), Cancer Treatment and Pharmacology (17 papers), Chronic Lymphocytic Leukemia Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Lymphoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Hematology (832 citations), Oncology (574 citations) and Genetics (190 citations). Marta Krejčí has collaborated with scholars based in Czechia, Greece and United States. Frequent co-authors include Roman Hájek, Zdeněk Adam, Jiřı́ Mayer, Luděk Pour, Jiří Vorlíček, Tomáš Büchler, Zdeněk Adam, Paul Cheng, Brian G.M. Durie and Noopur Raje. Their work appears in journals such as Blood, PLoS ONE and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.